Antiviral, Antifungal and Antibacterial Activities of a BODIPY-Based Photosensitizer.

ABSTRACT: Antimicrobial photodynamic inactivation (aPDI) employing the BODIPY-based photosensitizer 2,6-diiodo-1,3,5,7-tetramethyl-8-(N-methyl-4-pyridyl)-4,4'-difluoro-boradiazaindacene (DIMPy-BODIPY) was explored in an in vitro assay against six species of bacteria (eight total strains), three species of yeast, and three viruses as a complementary approach to their current drug-based or non-existent treatments. Our best results achieved a noteworthy 5-6 log unit reduction in CFU at 0.1 ?M for Staphylococcus aureus (ATCC-2913), methicillin-resistant S. aureus (ATCC-44), and vancomycin-resistant Enterococcus faecium (ATCC-2320), a 4-5 log unit reduction for Acinetobacter baumannii ATCC-19606 (0.25 ?M), multidrug resistant A. baumannii ATCC-1605 (0.1 ?M), Pseudomonas aeruginosa ATCC-97 (0.5 ?M), and Klebsiella pneumoniae ATCC-2146 (1 ?M), and a 3 log unit reduction for Mycobacterium smegmatis mc2155 (ATCC-700084). A 5 log unit reduction in CFU was observed for Candida albicans ATCC-90028 (1 ?M) and Cryptococcus neoformans ATCC-64538 (0.5 ?M), and a 3 log unit reduction was noted for Candida glabrata ATCC-15545 (1 ?M). Infectivity was reduced by 6 log units in dengue 1 (0.1 ?M), by 5 log units (0.5 ?M) in vesicular stomatitis virus, and by 2 log units (5 ?M) in human adenovirus-5. Overall, the results demonstrate that DIMPy-BODIPY exhibits antiviral, antibacterial and antifungal photodynamic inactivation at nanomolar concentrations and short illumination times.

SUBMITTER: Carpenter BL 

PROVIDER: S-EPMC6272413 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature